Skip to main content
SEED INNOVATIONS LIMITED logo

SEED INNOVATIONS LIMITED — Investor Relations & Filings

Ticker · SEED ISIN · GB00B7VX6J75 LEI · 213800KV6ETTB1BRZ435 IL Financial and insurance activities
Open in API
Filings indexed 467 across all filing types
Latest filing 2023-02-21 Regulatory Filings
Country GG Guernsey
Listing IL SEED

About SEED INNOVATIONS LIMITED

https://seedinnovations.co/

SEED INNOVATIONS LIMITED is an investment company specializing in early-stage ventures. The firm focuses on providing investors with exposure to disruptive life sciences and technology companies, with a developing strategic emphasis on high-growth sectors such as humanoid robotics and artificial intelligence (AI). The company actively manages its multi-sector portfolio, supporting the growth and success of its investee companies to generate long-term capital growth. Its model aims to make investment opportunities, often reserved for private venture capital firms, accessible to a broader investor base.

Recent filings

Filing Released Lang Actions
Portfolio Company Update: South West Brands
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number : 4998Q' and contains standard boilerplate language referencing 'RNS, the news service of the London Stock Exchange' and 'Market Abuse Regulation (EU) No. 596/2014'. The content itself is a brief update regarding a portfolio company's loan note maturity and repayment discussions. Given its format as a short, time-sensitive announcement distributed via the RNS system, and the explicit mention of RNS distribution, it fits best under the general Regulatory Filings category, as it is not a specific financial report (like 10-K or IR) or a specific corporate action announcement (like DIV or DIRS). It is a general regulatory disclosure.
2023-02-21 English
Investee Company Update: Little Green Pharma Ltd
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 0236Q' and is dated 15 February 2023. It is an update from SEED Innovations Limited regarding its investee company, Little Green Pharma Ltd, detailing an announcement made by LGP on the ASX concerning ethics approval for a psilocybin clinical trial. The structure, the presence of the RNS number, the date, and the nature of the content (a brief update on an investee company's operational news) strongly suggest this is a regulatory news service announcement. Since it is a general regulatory announcement that doesn't fit the specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Earnings Release (ER), the most appropriate classification is the general regulatory filing category, RNS.
2023-02-15 English
Investee Company Update: Yooma Wellness Inc.
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 7630P' and is dated February 13, 2023. It reports on an update from an investee company (Yooma Wellness Inc.) regarding operational restructuring, asset sales, debt settlements, and potential insolvency proceedings. The structure, use of RNS numbering, and the nature of the announcement (corporate update/news) strongly indicate a regulatory news service release. Since this is a general corporate announcement that doesn't fit neatly into specific financial reports (like 10-K, ER, IR) or specific corporate actions (like DIV, CAP, DIRS), the most appropriate classification is the general regulatory filing category.
2023-02-13 English
Investee Company Update: Avextra
Environmental & Social Information Classification · 99% confidence The document is an announcement released via RNS (RNS Number : 4292P) by SEED Innovations Limited. The content primarily relays an update about one of its portfolio companies, Avextra AG, specifically regarding a successful export of medical cannabis products to the UK. This is a general corporate update concerning an investee company's operational milestone. It is not a formal financial report (like 10-K or IR), a management discussion (MDA), or a specific regulatory filing like a Director's Dealing (DIRS) or Capital Change (SHA). Since it is a general announcement distributed through the RNS system, and it doesn't fit neatly into the more specific categories like ER, DIV, or CT, the most appropriate classification is the general regulatory announcement category, RNS, which serves as a broad category for such news releases.
2023-02-09 English
Investee Company Update: Little Green Pharma Ltd
Legal Proceedings Report Classification · 99% confidence The document begins with an 'RNS Number' and is dated '06 February 2023'. It is an announcement from SEED Innovations Limited regarding an update on its investee company, Little Green Pharma Ltd, specifically concerning regulatory changes affecting psychedelics (Psilocybin and MDMA) in Australia. The structure, use of RNS identifiers, and the nature of reporting on an investee company's operational/regulatory news strongly suggest this is a general regulatory announcement disseminated via the RNS service. Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a dividend notice (DIV), the most appropriate classification is the general regulatory filing category.
2023-02-06 English
Investee Company Update: Little Green Pharma Ltd
Earnings Release Classification · 100% confidence The document is an RNS announcement (RNS Number : 8747M) from Seed Innovations Limited. It explicitly states that it is noting an announcement released by its portfolio company, Little Green Pharma Ltd ('LGP'), regarding its quarterly results for the period ending 31 December 2022. The text provides highlights and key cash flow figures from the LGP quarterly report and includes a direct link to the full 'Quarterly Activities Report Appendix 4C' on LGP's website. Since this document is an announcement *about* another company's quarterly results, and it is distributed via RNS, it functions as a regulatory update or news release. Given the content summarizes key financial performance metrics for a period shorter than a year (quarterly results), it relates to interim financial reporting. However, the primary function of this specific document is to disseminate news via the RNS system, referencing another company's quarterly report. Because it is a short announcement referencing a full report and is distributed via RNS, it fits best as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it were the primary company's own results. Since it is an update on an *investee* company's quarterly results, and it is clearly marked as an RNS release, the most appropriate classification is RNS, as it is a general regulatory announcement providing portfolio news, rather than a comprehensive Interim Report (IR) or a primary Earnings Release (ER) for Seed Innovations itself. The document length is moderate (6939 chars), but its structure is that of a news bulletin pointing to the actual financial document. Q4 2022
2023-01-16 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.